Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of Sarcopenia on Non-Alcoholic Fatty Liver Disease
Michihiro Iwaki, Takashi Kobayashi, Asako Nogami, et al.
Nutrients (2023) Vol. 15, Iss. 4, pp. 891-891
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review
Wah‐Kheong Chan, Kee Huat Chuah, Ruveena Bhavani Rajaram, et al.
Journal of Obesity & Metabolic Syndrome (2023) Vol. 32, Iss. 3, pp. 197-213
Open Access | Times Cited: 201
Natural history of lean and non-lean metabolic dysfunction-associated steatotic liver disease
Shun‐ichi Wakabayashi, Nobuharu Tamaki, Takefumi Kimura, et al.
Journal of Gastroenterology (2024) Vol. 59, Iss. 6, pp. 494-503
Closed Access | Times Cited: 7
Inter-organ metabolic interaction networks in non-alcoholic fatty liver disease
Yuhong Fan, Siyao Zhang, Ye Wang, et al.
Frontiers in Endocrinology (2025) Vol. 15
Open Access
Muscle Strength and Cardiovascular Health in MASLD: A Prospective Study
Birgül Fatma Kumbaroğlu, Yasemin Balaban, Tülin Düger
Medicina (2025) Vol. 61, Iss. 2, pp. 247-247
Open Access
Sarcopenia as a Risk Factor for Mortality in NAFLD: How Should We Diagnose It?
Catherine Stankevicius, R H Davis, Dep Huynh, et al.
Journal of Digestive Diseases (2025)
Closed Access
Relevant Aspects of Combined Protocols for Prevention of N(M)AFLD and Other Non‐Communicable Diseases
Luis A. Videla, Rodrigo Valenzuela, Jessica Zúñiga‐Hernández, et al.
Molecular Nutrition & Food Research (2024) Vol. 68, Iss. 7
Closed Access | Times Cited: 5
GLP-1 receptor agonists in the treatment of diabetic non–alcoholic steatohepatitis patients
Ernest Adeghate
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 3, pp. 223-232
Open Access | Times Cited: 4
Sarcopenia and metabolic dysfunction associated steatotic liver disease: Time to address both
Rochelle Wong, Liyun Yuan
World Journal of Hepatology (2024) Vol. 16, Iss. 6, pp. 871-877
Open Access | Times Cited: 4
The prevalence and effects of sarcopenia in patients with metabolic dysfunction-associated steatotic liver disease (MASLD): A systematic review and meta-analysis
Xiaoyan Li, Jie He, Qiuhua Sun
Clinical Nutrition (2024) Vol. 43, Iss. 9, pp. 2005-2016
Open Access | Times Cited: 4
Sodium-glucose co-transporter 2 inhibitors and Sarcopenia: A controversy that must be solved
Barış Afşar, Rengin Elsürer Afşar
Clinical Nutrition (2023) Vol. 42, Iss. 12, pp. 2338-2352
Closed Access | Times Cited: 11
Association of systemic inflammatory indices with anthropometric measures, metabolic factors, and liver function in non-alcoholic fatty liver disease
Sara Arefhosseini, Taha Aghajani, Helda Tutunchi, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Quick and easy assessment of sarcopenia in cirrhosis: Can ultrasound be the solution?
Francesca Campani, Tancredi Vincenzo Li Cavoli, Umberto Arena, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 17, pp. 2287-2293
Open Access | Times Cited: 2
Association between non-alcoholic fatty liver disease and risk of sarcopenia: a systematic review and meta-analysis
Chao Deng, Qifeng Ou, Xuee Ou, et al.
BMJ Open (2024) Vol. 14, Iss. 5, pp. e078933-e078933
Open Access | Times Cited: 2
Sex difference in skeletal muscle mass in relation to metabolic dysfunction-associated steatotic liver disease: a propensity score matching study
Da‐Hye Son, Yu‐Jin Kwon, Jun‐Hyuk Lee
The journal of nutrition health & aging (2024) Vol. 28, Iss. 6, pp. 100270-100270
Open Access | Times Cited: 2
Polyphenols improve non‐alcoholic fatty liver disease via gut microbiota: A comprehensive review
Kimia Mohammadhasani, Mohammad Vahedi Fard, Ali Mottaghi Moghaddam Shahri, et al.
Food Science & Nutrition (2024) Vol. 12, Iss. 8, pp. 5341-5356
Open Access | Times Cited: 2
The relationship between muscle mass and fat content in body composition and non-alcoholic fatty liver disease in the Chinese general population: a cross-sectional study
Guoqiong Xu, Yuanyuan Wu, Jie Chen, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 2
The Role of Exercise in Steatotic Liver Diseases: An Updated Perspective
Iyiad Alabdul Razzak, Ahmed Fares, Jonathan G. Stine, et al.
Liver International (2024) Vol. 45, Iss. 1
Closed Access | Times Cited: 2
Gynostemma pentaphyllum Extract Alleviates NASH in Mice: Exploration of Inflammation and Gut Microbiota
Feng-Yan Jiang, Siran Yue, Yi-Yun Tan, et al.
Nutrients (2024) Vol. 16, Iss. 11, pp. 1782-1782
Open Access | Times Cited: 1
Association of muscle mass, grip strength and fat-to-muscle ratio and metabolic dysfunction-associated steatotic liver disease in a middle-to-elderly aged population
Si‐Yang Liu, Yajun He, Genfeng Yu, et al.
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 1
Association between triglyceride glucose-body mass index and the staging of non-alcoholic steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease
Fan Zhang, Yan Han, Yunfei Wu, et al.
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 1
Body Composition and Progression of Biopsy‐Proven Non‐Alcoholic Fatty Liver Disease in Patients With Obesity
Qianyi Wan, Xingzhu Liu, Jinghao Xu, et al.
Journal of Cachexia Sarcopenia and Muscle (2024)
Open Access | Times Cited: 1
The NRF-2/HO-1 Signaling Pathway: A Promising Therapeutic Target for Metabolic Dysfunction-Associated Steatotic Liver Disease
Na Li, Liyuan Hao, Shenghao Li, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 8061-8083
Open Access | Times Cited: 1
Gestational and Developmental Contributors of Pediatric MASLD
Marialena Mouzaki, Jessica G. Woo, Senad Divanovic
Seminars in Liver Disease (2024) Vol. 44, Iss. 01, pp. 043-053
Closed Access
Triglyceride-Targeted Molecularly Imprinted Polymers Activate Lipophagy via Cargo Exchange for Nonalcoholic Fatty Liver Disease Treatment
Yilin Wen, Ping Weng, Yueyue Li, et al.
ACS Applied Polymer Materials (2024) Vol. 6, Iss. 12, pp. 7265-7277
Closed Access
Relationship between phase angle measured with bioelectrical impedance analysis and nonalcoholic fatty liver disease in adults
Cansu Memiç İnan, Mustafa Çapraz
Nutrition & Food Science (2024) Vol. 54, Iss. 8, pp. 1487-1497
Closed Access
Page 1 - Next Page

Scroll to top